Tag: investing in psychedelic companies
PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform
Psychedelic-focused Media, E-commerce and Event Company DELIC Holdings to Begin Trading on the Canadian Securities Exchange Under Ticker Symbol “DELC”
Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds
Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council
Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone
Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory
PSYC Revamps Their Online Presence with a Relaunch of Corporate Website
